GlaxoSmithKline
-
Pharmacy Business
'The Top Line' podcast: COVID therapies dominate 2021’s top selling drugs, raising the curtain on ASCO 2022, plus this week's headlines
‘The Top Line’ podcast: COVID therapies dominate 2021’s top selling drugs, raising the curtain on ASCO 2022, plus this week’s…
Read More » -
Pharmacy Business
Pfizer, already flush with cash, will reap $16B from selling shares in GSK consumer health spinoff
Pfizer, already flush with cash, will reap $16B from selling shares in GSK consumer health spinoff aliu Wed, 06/01/2022 –…
Read More » -
Pharmacy Business
GSK's ViiV adds a new, unexpected demographic to Dovato campaign
GSK’s ViiV adds a new, unexpected demographic to Dovato campaign sharon.coey Fri, 05/27/2022 – 06:11
Read More » -
Pharmacy Business
New patent expiration for Glaxosmithkline drug ADVIL PM – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxosmithkline drug ADVIL PM Annual Drug Patent Expirations for ADVIL+PM…
Read More » -
Pharmacy Business
GSK's ViiV to work with Medicines Patent Pool, generic manufacturers to bolster access to long-acting HIV prevention med Apretude
GSK’s ViiV to work with Medicines Patent Pool, generic manufacturers to bolster access to long-acting HIV prevention med Apretude fkansteiner…
Read More » -
Pharmacy Business
'The Top Line' podcast: The aftermath of Roche’s failed TIGIT, Big Pharma's Q1 growth vs mRNA stars, plus this week's headlines
‘The Top Line’ podcast: The aftermath of Roche’s failed TIGIT, Big Pharma’s Q1 growth vs mRNA stars, plus this week’s…
Read More » -
Pharmacy Business
GlaxoSmithKline is no more: Meet the scaled down 'GSK'
GlaxoSmithKline is no more: Meet the scaled down ‘GSK’ badams Mon, 05/16/2022 – 12:58
Read More » -
Pharmacy Business
GSK's ViiV, Horizon and Pfizer earn top scores from U.S. patient groups: survey
GSK’s ViiV, Horizon and Pfizer earn top scores from U.S. patient groups: survey nmissakian Thu, 05/12/2022 – 18:03
Read More »